{"nctId":"NCT01367249","briefTitle":"Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery","startDateStruct":{"date":"2011-05"},"conditions":["Pain","Inflammation","Cataract"],"count":440,"armGroups":[{"label":"Bromfenac Ophthalmic Solution","type":"EXPERIMENTAL","interventionNames":["Drug: Bromfenac Ophthalmic Solution"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Bromfenac Ophthalmic Solution","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female at least 18 years of age who are scheduled for unilateral cataract surgery\n\nExclusion Criteria:\n\n* Have known hypersensitivity to bromfenac or to any component of the investigational product","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Ocular Inflammation","description":"The proportion of subjects who had cleared ocular inflammation summed ocular inflammation score (SOIS) of grade 0 by Day 15.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"108","spread":null},{"groupId":"OG001","value":"53","spread":null}]}]}]},{"type":"SECONDARY","title":"Ocular Pain","description":"The proportion of subjects who were free of ocular pain at Day 1. Pain Free defined as a score of \"None\" on the pain scale of the Ocular Comfort Grading Assessment in the subject diary.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"175","spread":null},{"groupId":"OG001","value":"108","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":212},"commonTop":["Eye Pain","Anterior Chamber Inflammation","Conjunctival Hyperemia","Photophobia"]}}}